Home › Funds › American National Bank of Texas › ABT

American National Bank of Texas position in ABT

ABBOTT LABORATORIES · Health Care

American National Bank of Texas reported holding 3,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$296K, representing 0.27% of its reported portfolio and ranking #38 among its reported holdings. American National Bank of Texas has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)3.00K sh
Reported value held$296.49K
Portfolio Weight0.27%
First reportedQ3 2025
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How American National Bank of Texas's ABT position evolved

American National Bank of Texas first disclosed a stake in ABT in Q3 2025 at 3,329 shares (US$446K). Across 5 filings, American National Bank of Texas increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,000 shares valued at US$296K — a reduction of -279 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.33K $445.89K New
Q4 2025 3.41K $426.99K Add
Q1 2026 3.41K $349.90K Hold
Q2 2026 3.28K $297.54K Reduce
Q3 2026 3.00K $296.49K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has American National Bank of Texas held ABT?

American National Bank of Texas has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is American National Bank of Texas's current position in ABT?

As of Q3 2026, American National Bank of Texas holds 3.00K shares of ABT (ABBOTT LABORATORIES), valued at $296.49K, representing 0.27% of its reported portfolio and ranking #38.

Has American National Bank of Texas been buying or selling ABT?

In the latest 13F filing (Q3 2026), American National Bank of Texas reduced its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.